Further, an RNA sequencing study examining cardiac hypertrophy demonstrated that SPI1 was significantly up-regulated in the pathogenesis of adverse myocardial remodeling (Song et al., 2012). The gene discussed is SPI1; the disease is cardiac hypertrophy.